CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

free stock cash Tips

Thursday, April 10, 2014

INDIAN BENCHMARK see a negative start on account of weak global cues. Piramal Enterprises sold the stake comprising 45.4mn shares of Vodafone India for Rs89bn to Prime Metal, an indirect subsidiary of Vodafone Plc.
FURTHER, Natco Pharma Ltd has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc’s breakthrough hepatitis C drug Sovaldi a patent in India. Tatas likely to invest another Rs 2,000 crore in their loss-making wireless telephony firm as equity within the next two years to service its loans.

Trend in FII flows: The FIIs were net buyers of Rs.342cr in the cash segment on Thursday while the domestic institutional investors (DIIs) were net buyers of Rs. 13cr, as per the provisional figures released by the NSE.

For More Detail Call Us 0731-6790000,6669900 
Click Here capitalstars.com


Post a Comment